<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35294563</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-1588</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz</Title><ISOAbbreviation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz</ISOAbbreviation></Journal><ArticleTitle>[Organ-specific sequelae of COVID-19 in adults].</ArticleTitle><Pagination><StartPage>462</StartPage><EndPage>470</EndPage><MedlinePgn>462-470</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00103-022-03513-2</ELocationID><Abstract><AbstractText>Organ-specific sequelae after COVID-19 occur frequently and are highly diverse in their features. Sequelae and symptoms persisting for more than four&#xa0;weeks after COVID-19 define the condition "long COVID."Organ-specific sequelae of COVID-19 generally occur more often after severe disease. Yet, duration and intensity of organ-specific sequelae are highly variable. While pulmonary sequelae typically persist after more severe acute disease, COVID-19 sequelae may also develop weeks after infection and can affect any organ. The degree of SARS-CoV&#x2011;2 specificity of COVID-19 sequelae, however, remains unclear. Thus, diagnosis and treatment of COVID-19 sequelae represent an interdisciplinary challenge. Diagnostic and therapeutic approaches are guided by type, extent, and cause of the specific sequelae as targeted therapy options for long COVID are lacking.In the present work, we review current knowledge regarding the prevalence/incidence, duration, specificity, type, and extent of organ-specific COVID-19 sequelae and summarize current diagnostic and therapeutic strategies (as of November 2021).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hennigs</LastName><ForeName>Jan K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Pneumologie, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Martinistr.&#xa0;52, 20246, Hamburg, Deutschland. j.hennigs@uke.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>II. Medizinische Klinik und Poliklinik, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Hamburg, Deutschland. j.hennigs@uke.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oqueka</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Pneumologie, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Martinistr.&#xa0;52, 20246, Hamburg, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>II. Medizinische Klinik und Poliklinik, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harbaum</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Pneumologie, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Martinistr.&#xa0;52, 20246, Hamburg, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>II. Medizinische Klinik und Poliklinik, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klose</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Pneumologie, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Martinistr.&#xa0;52, 20246, Hamburg, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>II. Medizinische Klinik und Poliklinik, Universit&#xe4;tsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Organbezogene Folgeerscheinungen von COVID&#x2011;19 bei Erwachsenen.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz</MedlineTA><NlmUniqueID>101181368</NlmUniqueID><ISSNLinking>1436-9990</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Organbezogene Folgeerscheinungen nach COVID-19 sind h&#xe4;ufig und vielgestaltig. Ab 4&#xa0;Wochen nach Akutinfektion mit SARS-CoV&#x2011;2 werden sie unter dem Begriff &#x201e;Long-COVID&#x201c; zusammengefasst.Nach schweren Akutverl&#xe4;ufen treten organbezogene Folgeerscheinungen h&#xe4;ufiger auf. Dauer und Intensit&#xe4;t variieren jedoch interindividuell stark. Die SARS-CoV-2-Spezifit&#xe4;t der Folgeerscheinungen ist ebenfalls weiter unklar. W&#xe4;hrend sich in der Fr&#xfc;hphase nach schweren Verl&#xe4;ufen zumeist pulmonale Folgeerscheinungen einstellen, m&#xfc;ssen diese nicht auf die Lunge begrenzt bleiben, sondern k&#xf6;nnen prinzipiell jedes Organ betreffen. Die ad&#xe4;quate Diagnostik von COVID-19-Folgeerscheinungen stellt daher eine interdisziplin&#xe4;re Herausforderung dar. Auch die Therapie richtet sich nach Art, Umfang und Ursache der jeweiligen Folgeerscheinung. Allgemeinmedikament&#xf6;se oder zielgerichtete Therapieoptionen gegen Long-COVID bestehen bisher nicht.Im vorliegenden &#xdc;bersichtsartikel berichten wir &#xfc;ber H&#xe4;ufigkeit, Dauer, Spezifit&#xe4;t sowie Art und Umfang organspezifischer COVID-19-Folgeerscheinungen und geben einen &#xdc;berblick &#xfc;ber diagnostisches und therapeutisches Vorgehen (mit Datenstand November 2021).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long Haulers</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Sequelae</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35294563</ArticleId><ArticleId IdType="pmc">PMC8925979</ArticleId><ArticleId IdType="doi">10.1007/s00103-022-03513-2</ArticleId><ArticleId IdType="pii">10.1007/s00103-022-03513-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a&#xa0;retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U et al (2021) S1-Leitlinie Post-COVID/Long-COVID. AWMF online. https://www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2021-07.pdf:1-76. Zugegriffen: 10. Nov. 2021</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a&#xa0;systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. www.nice.org.uk/guidance/ng188. Zugegriffen: 10. Nov. 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihr (2021) Living with COVID19. Second Review. 10.3310/themedreview_45225. Zugegriffen: 10. Nov. 2021</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;cruz RF, Waller MD, Perrin F et al (2021) Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 10.1183/23120541.00655-2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Pawelek P, Gaughan C (2021) Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. Office for National Statistics, Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021. Zugegriffen: 10. Nov. 2021</Citation></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a&#xa0;longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FVC, Meys R, Delbressine JM, et al. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021;19:40. doi: 10.1186/s12955-021-01691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical Characterisation protocol. Lancet Reg Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard CE, S&#xfc;tsch C, Bengs S, et al. Sex- and gender-specific risk factors of post-COVID-19 syndrome: a population-based cohort study in Switzerland. 2021.</Citation></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent symptoms following SARS-CoV-2 infection in a&#xa0;random community sample of 508,707 people. 2021.</Citation></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutou AK, Asimakos A, Kortianou E, Vogiatzis I, Tzouvelekis A. J Pers Med. 2021;11(838):19. doi: 10.3390/jpm11090838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11090838</ArticleId><ArticleId IdType="pmc">PMC8469288</ArticleId><ArticleId IdType="pubmed">34575615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, et al. Eur Respir J. 2020;55(2001217):19. doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J, Debray MP, Gilbert M, et al. Eur Respir J. 2020;56(2001754):2. doi: 10.1183/13993003.01754-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01754-2020</ArticleId><ArticleId IdType="pmc">PMC7301832</ArticleId><ArticleId IdType="pubmed">32554533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum TV, Aalokken TM, Bronstad E, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021;57:2003448. doi: 10.1183/13993003.03448-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Chen S, Zhang Y et al (2021) Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19&#x202f;at 3&#x2011;month follow-up. Eur Respir J 58:2003677. 10.1183/13993003.03677-2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a&#xa0;cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D, Guido G, Zerunian M, et al. Postacute sequelae of COVID-19 pneumonia: 6-month chest CT follow-up. Radiology. 2021 doi: 10.1148/radiol.2021210834:210834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210834:210834</ArticleId><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18:799&#x2013;806. doi: 10.1513/AnnalsATS.202008-1002OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57:2003481. doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a&#xa0;prospective study. Lancet Respir Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs JK, Huwe M, Hennigs A, et al. Respiratory muscle dysfunction in COVID-19 patients with persistent symptoms. ResearchSquare. 2021 doi: 10.21203/rs.3.rs-904738/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-904738/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R, Bogue T, Koshy A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136:1342&#x2013;1346. doi: 10.1182/blood.2020007938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007938</ArticleId><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med. 2020;174:106197. doi: 10.1016/j.rmed.2020.106197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106197</ArticleId><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Davogustto GE, Clark DE, Hardison E, et al. Characteristics associated with multisystem inflammatory syndrome among adults with SARS-coV-2 infection. JAMA Netw Open. 2021;4:e2110323. doi: 10.1001/jamanetworkopen.2021.10323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.10323</ArticleId><ArticleId IdType="pmc">PMC8134998</ArticleId><ArticleId IdType="pubmed">34009351</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39:405&#x2013;407. doi: 10.1016/j.healun.2020.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2020.03.012</ArticleId><ArticleId IdType="pmc">PMC7118652</ArticleId><ArticleId IdType="pubmed">32362390</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Crameri GAG, Bielecki M, Zust R, Buehrer TW, Stanga Z, Deuel JW. Reduced maximal aerobic capacity after COVID-19 in young adult recruits, Switzerland, May 2020. Euro Surveill. 2020;25:2001542. doi: 10.2807/1560-7917.ES.2020.25.36.2001542.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.36.2001542</ArticleId><ArticleId IdType="pmc">PMC7502899</ArticleId><ArticleId IdType="pubmed">32914744</ArticleId></ArticleIdList></Reference><Reference><Citation>Salisbury R, Iotchkova V, Jaafar S, et al. Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up. Blood Adv. 2020;4:6230&#x2013;6239. doi: 10.1182/bloodadvances.2020003349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003349</ArticleId><ArticleId IdType="pmc">PMC7757009</ArticleId><ArticleId IdType="pubmed">33351117</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, Lutgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383:590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol. 2021 doi: 10.1038/s41581-021-00487-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Lee CW, Park DI, et al. Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID-19 in Korea. Clin Gastroenterol Hepatol. 2021;19:1387&#x2013;1394.e2. doi: 10.1016/j.cgh.2020.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.06.005</ArticleId><ArticleId IdType="pmc">PMC7286243</ArticleId><ArticleId IdType="pubmed">32534042</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116:1077&#x2013;1082. doi: 10.14309/ajg.0000000000001154.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001154</ArticleId><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimboli P, Camponovo C, Scappaticcio L, Bellastella G, Piccardo A, Rotondi M. Thyroid sequelae of COVID-19: a&#xa0;systematic review of reviews. Rev Endocr Metab Disord. 2021;22:485&#x2013;491. doi: 10.1007/s11154-021-09653-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09653-1</ArticleId><ArticleId IdType="pmc">PMC8038866</ArticleId><ArticleId IdType="pubmed">33843008</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Kilian C, Turner JE, et al. Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19. patients. Sci Immunol. 2021;6:eabf6692. doi: 10.1126/sciimmunol.abf6692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abf6692</ArticleId><ArticleId IdType="pmc">PMC8128299</ArticleId><ArticleId IdType="pubmed">33622974</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to COVID-19. Sci Immunol. 2020;5:eabe8063. doi: 10.1126/sciimmunol.abe8063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe8063</ArticleId><ArticleId IdType="pubmed">33208380</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter AG, Shields AM, Karim A, et al. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol. 2021;205:99&#x2013;105. doi: 10.1111/cei.13623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13623</ArticleId><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Maddukuri G, Al-Aly Z. Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study. BMJ. 2020;371:m4677. doi: 10.1136/bmj.m4677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4677</ArticleId><ArticleId IdType="pmc">PMC7735416</ArticleId><ArticleId IdType="pubmed">33323357</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutenbrunner C, Nugraha B, Martin LT. Phase-adapted rehabilitation for acute Coronavirus disease-19 patients and patient with long-term sequelae of Coronavirus disease-19. Am J Phys Med Rehabil. 2021;100:533&#x2013;538. doi: 10.1097/PHM.0000000000001762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001762</ArticleId><ArticleId IdType="pubmed">33901039</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, Leitl D, Jarosch I, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021 doi: 10.1183/23120541.00108-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00108-2021</ArticleId><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Abodonya AM, Abdelbasset WK, Awad EA, Elalfy IE, Salem HA, Elsayed SH. Inspiratory muscle training for recovered COVID-19&#xa0;patients after weaning from mechanical ventilation: a pilot control clinical study. Medicine. 2021;100:e25339. doi: 10.1097/MD.0000000000025339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000025339</ArticleId><ArticleId IdType="pmc">PMC8021337</ArticleId><ArticleId IdType="pubmed">33787632</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a&#xa0;prospective, community-based, nested, case-control study. Lancet Infect Dis. 2021 doi: 10.1016/s1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: a case series. Ann Intern Med. 2021;174:1334&#x2013;1336. doi: 10.7326/M21-1976.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1976</ArticleId><ArticleId IdType="pmc">PMC8252827</ArticleId><ArticleId IdType="pubmed">34029484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>